Download presentation
Presentation is loading. Please wait.
Published byGeorgia O’Neal’ Modified over 9 years ago
1
Division of Surgical, Molecular and Ultrastructural Pathology University of Pisa Pisa University Hospital g.bevilacqua@med.unipi.it Research Doctorate in Molecular and Experimental Oncology 13431338
2
UNKNOWN PRIMARY TUMORS a vanishing chapter of pathology
3
METASTASISPRIMARY ????????
4
CUP – Carcinoma of Unknown Primary UPC – Unknown Primary Cancer ACUP – Adeno Carcinoma of Unknown Primary UPT – Unknown Primary Tumor OPT – Occult Primary Tumor
5
a biopsy-proven metastatic malignancy this diagnosis requires: after a thorough clinical evaluation that includes physical examination and laboratory and imaging diagnostic tests no identifiable primary tumor
6
5 % of all metastatic cancer
7
CUP - UPC - UPT - OPT source identification: - molecular profiling: 60 – 85 % - morphology, IHC: 20 – 30 % of cases
8
CUP - UPC - UPT - OPT prognosis: worst than in cases with known primary
9
??????????? CUP - UPC - UPT - OPT
10
matter of size CUP - UPC - UPT - OPT
11
0 mm few mm CUP - UPC - UPT - OPT
12
0 mm: SPONTANEOUS REGRESSION few mm CUP - UPC - UPT - OPT
13
SPONTANEOUS REGRESSION of a TUMOR 1 : 60,000 – 100,000 cases ?????????????
14
SPONTANEOUS REGRESSION of a CANCER 1 : 60,000 – 100,000 cases ischemia ????????????? immune response “unofficial” chemical compounds
15
Hicks AM et al: Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. PNAS 103: 7753–7758, 2006
16
size imaging CUP - UPC - UPT - OPT
17
PRE – IMAGING ERA
18
The lesson of Anatomy of Dott. Nicolaes Tulp Rembrandt, 1632
19
Prof. Rupert A WILLIS 1898 - 1980 in case of CUP - UPC - UPT - OPT LUNG
20
IMAGING & MOLECULAR PROFILING lung pancreas liver / bile ducts kidney / adrenals bowel genital system stomach bladder / ureter breast
21
small very aggressive CUP - UPC - UPT - OPT
22
ductal; NOS: not otherwise specified; NST: no special type lobular tubular / cribriform medullary mucinous papillary metaplastic apocrine 80% 10% 6%6% 2%2% 2%2% 1% < 1% breast carcinoma
23
DUCTALLOBULAR
24
sexual maturity aging pre-puberal
25
DCIS LCIS
26
INFILTRATING DUCTAL CARCINOMA DCIS: FREQUENT
27
LCIS: RARE INFILTRATING LOBULAR CARCINOMA
28
LOBULAR early loss of intercellular junctions DUCTAL late loss of intercellular junctions
29
terminal duct – lobule unit ductal carcinoma lobular carcinoma
31
DESTRUCTION of the LOBULE
32
natural history of a carcinoma 1 initiation:2 promotion: 3 progression: normal hyperplastic atypical cancer invasive metastatic
33
invasive cametastasis clones vascular invasion
34
CUP - UPC - UPT - OPT early acquisition of the invasive genotype / phenotype
35
CUP - UPC - UPT - OPT early acquisition of the invasive genotype / phenotype small primary early metastasis bad prognosis
36
PRIMARYMET or =
37
PRIMARY MET molecular characterization for molecular therapy
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.